Fabian Depis

Company: GentiBio

Job title: Director, Discovery Research

Seminars:

Generating EngTregs to Overcome Key Challenges Associated with the Successful Application of Treg Cell Therapeutics 11:30 am

Engineering abundant T cell populations with stabilized FOXP3 expression to create a scalable Treg Phenotype Utilizing an inducible chimeric receptor to provide highly specific and tunable IL-2 signaling support Providing tissue specificity and enhanced regulatory functions through antigenspecific CARs or TCRsRead more

day: Day Two